Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Tecedor

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Neuron|January 6, 2015
Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypesJohn H Lee, Luis Tecedor, Yong Hong Chen, et al.
JCI Insight|October 2, 2019
Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorderRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
Nature|February 2, 2022
Author Correction: Regulated control of gene therapies by drug-induced splicingAlex Mas Monteys, Amiel A Hundley, Paul T Ranum, et al.
Nature|July 29, 2021
Regulated control of gene therapies by drug-induced splicingAlex Mas Monteys, Amiel A Hundley, Paul T Ranum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2022
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulationRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
Molecular Therapy. Nucleic Acids|August 7, 2023
<i>VWA3A</i>-derived ependyma promoter drives increased therapeutic protein secretion into the CSFEllie M Carrell, Yong Hong Chen, Paul T Ranum, et al.
Science Translational Medicine|November 13, 2015
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten diseaseMartin L Katz, Luis Tecedor, Yonghong Chen, et al.
Science Translational Medicine|May 14, 2025
An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and miceLuis Tecedor, Yong Hong Chen, David E Leib, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuron|January 6, 2015
Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypesJohn H Lee, Luis Tecedor, Yong Hong Chen, et al.
JCI Insight|October 2, 2019
Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorderRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
Nature|February 2, 2022
Author Correction: Regulated control of gene therapies by drug-induced splicingAlex Mas Monteys, Amiel A Hundley, Paul T Ranum, et al.
Nature|July 29, 2021
Regulated control of gene therapies by drug-induced splicingAlex Mas Monteys, Amiel A Hundley, Paul T Ranum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2022
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulationRebecca C Ahrens-Nicklas, Luis Tecedor, Arron F Hall, et al.
Molecular Therapy. Nucleic Acids|August 7, 2023
<i>VWA3A</i>-derived ependyma promoter drives increased therapeutic protein secretion into the CSFEllie M Carrell, Yong Hong Chen, Paul T Ranum, et al.
Science Translational Medicine|November 13, 2015
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten diseaseMartin L Katz, Luis Tecedor, Yonghong Chen, et al.
Science Translational Medicine|May 14, 2025
An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and miceLuis Tecedor, Yong Hong Chen, David E Leib, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 2